Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
The gut microbiota and its correlations with the central nervous system disorders.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.

Pages